Pharmaron logo

Pharmaron

Pharmaron (Stock Code: 300759.SZ/3759.HK) is a premier R&D service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities, and established a broad spectrum of research, development and manufacturing service capabilities throughout the entire drug discovery, preclinical and clinical development process across multiple therapeutic modalities, including small molecules, biologics and CGT products. With over 17,000 employees and operations in China, the U.S., and the U.K., Pharmaron has an excellent track record in the delivery of R&D solutions to its partners in North America, Europe, Japan and China. Pharmaron is a contract research organization (CRO). Services: * Synthetic, medicinal and analytical chemistry services * Biology services * DMPK services * Pharmacology services * Drug safety assessment services * Radiochemistry and isotopically labelled metabolism services * Chemical & pharmaceutical development services * Clinical development services www.pharmaron.com CRO - Contract Research Organization Library Synthesis CADD Bioorganic Chemistry Discovery Process Chemistry Radiolabelled Chemical Synthesis ChemInformatics in vitro Biology in vitro Screening Structural Biology in vivo Pharmacology Animal Disease Models ex vivo Pharmacology Biomarkers in vitro ADME in vivo PK PKPD QA Regulatory Affairs Discovery Biologics Process Chemistry API Manufacturing Material Science Formulation Development Drug Product Manufacturing Toxicology Safety Pharmacology Genetic Toxicology DART Pathology Immunotoxicity Bioanalytical 14C / Carbon-14 Radiosynthesis 3H / Tritium Radiosynthesis QWBA mARG Clinical AME Mass Balance Metabolite Profiling Microdosing Phase 0 Absolute Bioavailability DDI First-in-Human (FIH) Thorough QT(TQT) Ethnobridging

Free account • No credit card • 5 profiles/day

Pharmaceutical Manufacturing 2,121 Employees Found Liverpool, United Kingdom Founded 2004 10 Similar Companies
2,121 Employees Found
91% Email Coverage
$4.2B Est Revenue
22 Office HQ
10 Similar Companies
Sep '26 Last Verified

Pharmaron – Company Information

Pharmaceutical Manufacturing
Founded 2004
1,001-5,000 employees View all
6 Taihe Road, Beijing, 100176, CN
Process Development Assay Development Discovery Formulation Pharmacology Chemistry Biology Lead Optimization Biologics DMPK Toxicology ADME Safety Pharmacology Preclinical analytical sciences API manufacturing Chemical Development clinical pharmacology accelerator mass spectrometry radiolabelled chemistry radiolabelled compounds CTG Products radiosynthesis

Frequently asked questions about Pharmaron

What is Pharmaron email format?

The widely used Pharmaron email format is {first}.{last} (e.g. john.smith@pharmaron.com) with 75% adoption across the company.

What is Pharmaron customer service number?

To contact Pharmaron customer service number in your country click here to find.

Who is the CEO of Pharmaron?

Boliang Lou is the CEO of Pharmaron.

Who are the decision makers in Pharmaron?

The decision makers in Pharmaron are Boliang Lou, Howe Li Li Hao, Katherine Lee, etc. Click to Find Pharmaron decision makers emails.

What types of services does Pharmaron offer in the life sciences industry?

Pharmaron provides a comprehensive range of R&D services tailored for the life sciences sector. Our offerings include process development, assay development, discovery services, formulation, pharmacology, chemistry, biology, lead optimization, and biologics. Additionally, we specialize in DMPK (Drug Metabolism and Pharmacokinetics), toxicology, ADME (Absorption, Distribution, Metabolism, and Excretion), safety pharmacology, preclinical studies, analytical sciences, API (Active Pharmaceutical Ingredient) manufacturing, and chemical development.

How does Pharmaron support drug development from discovery to preclinical stages?

Pharmaron supports drug development through a seamless integration of services that span from early discovery to preclinical stages. Our discovery services include target identification, lead optimization, and pharmacology studies. Once a lead compound is identified, we provide formulation development, toxicology assessments, and DMPK studies to ensure the compound's viability. Our experienced teams work collaboratively to streamline the process, ensuring that projects progress efficiently and effectively towards clinical trials.

What industries does Pharmaron serve?

Pharmaron primarily serves the pharmaceutical and biotechnology industries. Our clients range from large multinational corporations to small biotech firms. We also support academic institutions and research organizations that require specialized R&D services. Our expertise in various therapeutic areas, including oncology, neurology, and infectious diseases, allows us to cater to diverse client needs across the life sciences spectrum.

Can Pharmaron assist with regulatory submissions for clinical trials?

Yes, Pharmaron can assist clients with regulatory submissions for clinical trials. Our experienced regulatory affairs team provides guidance on the necessary documentation and compliance requirements for submissions to regulatory agencies. We help ensure that all preclinical data, including toxicology and pharmacokinetics, is well-documented and presented in a manner that meets regulatory standards, thereby facilitating a smoother transition to clinical trial phases.

What is the significance of Pharmaron's expertise in radiolabelled chemistry?

Pharmaron's expertise in radiolabelled chemistry is significant for drug development, particularly in pharmacokinetic studies and imaging applications. Radiolabelled compounds are essential for understanding the distribution and metabolism of drugs within the body. Our capabilities in radiosynthesis and the development of radiolabelled compounds enable clients to conduct advanced studies that provide critical insights into drug behavior, ultimately aiding in the optimization of therapeutic candidates.

How does Pharmaron ensure the quality and reliability of its R&D services?

Pharmaron ensures the quality and reliability of its R&D services through a robust quality management system that adheres to international standards. We implement rigorous quality control measures at every stage of the research process, from initial development through to final testing. Our teams are composed of highly trained professionals who follow established protocols and best practices to deliver consistent, high-quality results. Additionally, we regularly engage in internal audits and external inspections to maintain compliance and continuously improve our services.